1. Home
  2. PTCT vs NOV Comparison

PTCT vs NOV Comparison

Compare PTCT & NOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$76.82

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Logo NOV Inc.

NOV

NOV Inc.

HOLD

Current Price

$20.76

Market Cap

7.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTCT
NOV
Founded
1998
1862
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
7.0B
IPO Year
2006
1996

Fundamental Metrics

Financial Performance
Metric
PTCT
NOV
Price
$76.82
$20.76
Analyst Decision
Buy
Hold
Analyst Count
17
15
Target Price
$80.65
$19.47
AVG Volume (30 Days)
1.5M
3.1M
Earning Date
05-07-2026
04-27-2026
Dividend Yield
N/A
1.73%
EPS Growth
264.48
N/A
EPS
N/A
0.05
Revenue
$264,734,000.00
$8,744,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$17.70
$3.81
P/E Ratio
N/A
$402.60
Revenue Growth
36.19
N/A
52 Week Low
$43.18
$11.78
52 Week High
$90.87
$21.55

Technical Indicators

Market Signals
Indicator
PTCT
NOV
Relative Strength Index (RSI) 43.24 64.82
Support Level $74.45 $17.92
Resistance Level $79.67 $21.16
Average True Range (ATR) 3.27 0.51
MACD -1.01 0.25
Stochastic Oscillator 4.47 91.01

Price Performance

Historical Comparison
PTCT
NOV

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

About NOV NOV Inc.

NOV (formerly National Oilwell Varco) designs, manufactures, and sells a wide range of equipment and components supplying the oil and gas industry, including rig equipment, downhole tools, drill pipe, and well casing. NOV's customers include major integrated oil companies, national oil companies, independent oil and gas companies, and drilling contractors. Its operations are organized into two reportable segments: energy products and services and energy equipment. NOV operates on a global scale, with international markets contributing nearly two-thirds of its annual revenue.

Share on Social Networks: